Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Gains from Investment Securities (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Gains from Investment Securities for 2 consecutive years, with $10367.0 as the latest value for Q3 2023.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $10367.0 in Q3 2023 year-over-year; TTM through Dec 2023 was $165422.0, a N/A change, with the full-year FY2024 number at $1.4 million, up 13870.0% from a year prior.
  • Gains from Investment Securities was $10367.0 for Q3 2023 at LENZ Therapeutics, down from $1.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.7 million in Q2 2023 to a low of $10367.0 in Q3 2023.